Clinical Trial of Glatiramer Acetate in Amyotrophic Lateral Sclerosis (ALS)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00326625 |
Recruitment Status :
Completed
First Posted : May 17, 2006
Last Update Posted : February 20, 2018
|
Sponsor:
Teva Pharmaceutical Industries, Ltd.
Information provided by (Responsible Party):
Teva Pharmaceutical Industries ( Teva Pharmaceutical Industries, Ltd. )
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Completed |
---|---|
Actual Primary Completion Date : | June 30, 2008 |
Actual Study Completion Date : | July 31, 2008 |